Professor Vivekanand Jha shares his views on how Dialysis is one of the first technological innovations in medicine and why we need to leverage this technology to address the huge kidney failure burden our country faces.
A Disease may be Rare but Hope should not be!
On International Women’s Day, Biocon salutes the indomitable spirit of it’s Wonder Women!
CEO Speaks: On the major milestone for Biocon-Sandoz and how this collaboration will enable Biocon to address the next wave of Global Biosimilar Opportunities!
First Biosimilar Trastuzumab approved in the US
Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.
Mental health is one of the biggest issues facing our society today. Stress at the workplace is unavoidable. Here are a few simple strategies that can not only help you do your job better but also improve facets of your personal life.
Prasad Deshpande, Vice President & Head, SCM, Biocon shares his views on the impact of GST on Supply Chain in Pharma Sector.
Seema Ahuja, VP & Global Head of Communications,
Biocon speaks on Healthcare PR, key challenges faced by the Healthcare and Pharma businesses & how in-house communication teams manage and navigate regulatory issues.
BIOCON is awarded the “9th NATIONAL IPR AWARD FOR 2017” in the category “Top Indian Company for creating Global Brand” & also conferred with “WIPO USERS TROPHY”
Kiran Mazumdar-Shaw shares her views on how #digitalindia can transform lives, boost growth & propel us to double digit growth.
Arshad Jamil, General Manager, IPR, Biocon talks about Biocon’s IP strategy that is creating value by leveraging the potential of our innovative products & processes.